The Campbell Analysis

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

As its SPAC merger with Churchill Capital IX nears, PlusAI will meet investors at a key conference, showcasing its autonomous trucking tech and strategy.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

Guitar Center launches a new podcast hosted by its CEO, a strategic move to engage musicians and redefine its brand amid a major company turnaround.

As PuroClean surpasses 500 locations, its new partnership with KnowHow puts an AI expert in every technician's pocket to ensure consistent quality.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

Forrester names NICE Actimize a leader in APAC fraud solutions, citing its advanced AI as crucial for securing the region's booming digital economy.

A new joint venture between Corewell Health and Quest Diagnostics aims to reshape lab services across Michigan with a new high-tech facility and new efficiencies.

A new health initiative aims to fight chronic disease with personalized nutrition. But can data from your body truly fix a broken food system?

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

BitVentures diversifies into crypto, acquiring a 0.5 MW fleet of next-gen miners. Can its efficiency-focused strategy succeed in the competitive space?

With strong growth and key acquisitions, Haemonetics' CEO will lay out the company's vision for 2026 at a high-stakes investor conference.

A strategic partnership used deep learning AI to boost insurance leads by 32% and win major French awards. Here's how they did it.

Azores Labs launches Jumpo, an AI-powered kids' camera blending creativity and safety. But can it win over parents in a competitive tech market?

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

KORU Medical seeks FDA clearance for its FreedomEDGE® system with a key breast cancer drug, signaling a major shift in cancer care delivery.